BE902642A - Aryl-10 dihydroxy-1,8 antrhones et leurs esters leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique. - Google Patents

Aryl-10 dihydroxy-1,8 antrhones et leurs esters leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique.

Info

Publication number
BE902642A
BE902642A BE0/215174A BE215174A BE902642A BE 902642 A BE902642 A BE 902642A BE 0/215174 A BE0/215174 A BE 0/215174A BE 215174 A BE215174 A BE 215174A BE 902642 A BE902642 A BE 902642A
Authority
BE
Belgium
Prior art keywords
dihydroxy
aryl
human
veterinary medicine
antrhones
Prior art date
Application number
BE0/215174A
Other languages
English (en)
Inventor
B Shroot
G Lang
J Maignan
S Restle
Original Assignee
Galderma Rech Dermatologique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Rech Dermatologique filed Critical Galderma Rech Dermatologique
Publication of BE902642A publication Critical patent/BE902642A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Aryl-10 dihydroxy-1,8 anthrone de la formule générale I dans laquelle Ar represente un reste aromatique, substitué ou non et les substituants étant H, <hal, Cf3, OH, Alk, alcoxy, nitrile SO2NR1R2, divers heterocycles, ou autres utilisations en médecine humaine ou vétérinaire dans le traitement des tumeurs cancéreuses, du psoriasis, des verrues, eczéma et autres.
BE0/215174A 1984-06-13 1985-06-12 Aryl-10 dihydroxy-1,8 antrhones et leurs esters leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique. BE902642A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8409203A FR2565966B1 (fr) 1984-06-13 1984-06-13 Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Publications (1)

Publication Number Publication Date
BE902642A true BE902642A (fr) 1985-12-12

Family

ID=9304944

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215174A BE902642A (fr) 1984-06-13 1985-06-12 Aryl-10 dihydroxy-1,8 antrhones et leurs esters leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique.

Country Status (11)

Country Link
JP (1) JPS6140238A (fr)
BE (1) BE902642A (fr)
CA (1) CA1253859A (fr)
CH (1) CH664557A5 (fr)
DE (1) DE3521074A1 (fr)
DK (1) DK265185A (fr)
FR (1) FR2565966B1 (fr)
GB (1) GB2160864B (fr)
IT (1) IT1190365B (fr)
NL (1) NL8501699A (fr)
SE (1) SE459807B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31289A (en) * 1968-01-08 1974-01-14 Ciba Geigy Ag Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol
DE2154608A1 (de) * 1970-11-12 1972-06-29 Ciba-Geigy Ag, Basel (Schweiz) Neues Diacetat, pharmazeutische Präparate und Herstellungsverfahren
DE3002089A1 (de) * 1980-01-22 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue, substituierte 1,8-dihydroxy-9-(10h)-anthracenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2495934A1 (fr) * 1980-12-15 1982-06-18 Cird Composition pour le traitement du psoriasis a base d'une dihydroxy-1,8 anthrone-9 substituee en position 10

Also Published As

Publication number Publication date
SE8502910D0 (sv) 1985-06-12
JPS6140238A (ja) 1986-02-26
FR2565966A1 (fr) 1985-12-20
IT1190365B (it) 1988-02-16
CA1253859A (fr) 1989-05-09
DK265185A (da) 1985-12-14
NL8501699A (nl) 1986-01-02
DK265185D0 (da) 1985-06-12
SE8502910L (sv) 1985-12-14
SE459807B (sv) 1989-08-07
FR2565966B1 (fr) 1986-08-29
IT8521130A0 (it) 1985-06-12
CH664557A5 (fr) 1988-03-15
GB2160864A (en) 1986-01-02
GB2160864B (en) 1987-12-31
DE3521074A1 (de) 1985-12-19
GB8514973D0 (en) 1985-07-17

Similar Documents

Publication Publication Date Title
DE3568272D1 (en) 4-vinylbenzoic-acid derivatives, their preparation and their use as therapeutical compositions and as ligands
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
NL300209I2 (nl) Benzonaftaleenderivaten, werkwijze voor de bereiding ervan en hun toepassing op farmaceutisch en cosmetisch gebied.
ATE243525T1 (de) Zubereitungen aus immunogenen molekülen, die granulozyten-makrophagen-stimulierenden faktor als adjuvans enthalten
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
FR2378523A1 (fr) Medicament pour le traitement de l&#39;acne
PT873332E (pt) Compostos discodermolida e composicoes farmaceuticas que os contem para terapeutica do cancro
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
FR2415630A1 (fr) Nouvelles 5-vinyl-2-pyrrolidones, utiles notamment dans la preparation des acides 4-amino-5-hexenoique et 4-amino-5-hexynoique, et leur preparation
Jablońska et al. Ro 10-9359 in epidermodysplasia verruciformis. Preliminary report
IE35375L (en) Tetrahydronaphthyloxyaminopropanols
FR2374317A1 (fr) Derives d&#39;acide n-(benzothiazolyl-2)oxamique et procede pour leur preparation et leur utilisation comme medicament anti-allergique
BE902642A (fr) Aryl-10 dihydroxy-1,8 antrhones et leurs esters leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique.
EA199800865A1 (ru) Бензотиофены, содержащие их фармацевтические композиции и способы лечения патологических состояний с их использованием
FR2359153A1 (fr) Nouveaux esters carboxyliques d&#39;acide phosphonoacetique utiles notamment pour le traitement des infections d&#39;herpes simplex
FR2388789A1 (fr) Derives d&#39;acide benzoique, leur procede de preparation et leur application therapeutique
MA19952A1 (fr) Nouveaux derives de la nitrosouree, leur procede de preparation et les compositions pharmaceutiques les renfermant
JP2742982B2 (ja) 活性酸素消去剤
FR2421613A1 (fr) Compositions contenant des benzamides de 3-aminopyrrolidines et leur utilisation therapeutique pour le traitement des allergies
FR2380778A1 (fr) Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters
BE904605A (fr) Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique.
FR2644459B1 (fr) Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
ES438537A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1-(2&#39;, 4&#39;, 6&#39;,-trihidroxifenil)-propandiona-(1, 2) sustitui-dos en la posicion 3.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES

Effective date: 19930630